{
  "@context": "https://frontierpicks.com/schemas/dossier.v1.json",
  "ticker": "CMG",
  "name": "Chipotle Mexican Grill, Inc.",
  "url": "https://frontierpicks.com/dossiers/CMG/",
  "json_url": "https://frontierpicks.com/dossiers/CMG.json",
  "status": "DORMANT",
  "current_conviction": "MEDIUM",
  "graded_conviction": null,
  "archetype": {
    "code": "a1",
    "n": 1
  },
  "current_thesis": "Outbreak drawdown is repairing: the federal count rose from 345 cases/27 states (2026-08-14) to 431/32 (2026-08-19) while the stock went from a $33.50 close on 08-14 to $36.90 on 08-21, reclaiming the $35 shelf. CDC dates illness onsets 06-19 to 07-20, so the exposure window is closed — but nothing measures post-08-04 traffic before the ~2026-10-28 Q3 print.",
  "invalidation_trigger": "A weekly close below $34 surrenders the post-2026-08-14 recovery and puts price back inside the outbreak drawdown range; secondarily, a Q3 print (~2026-10-28, est.) with comparable-sales transactions negative YoY against +1.0% in Q2 2026.",
  "catalyst_date": null,
  "outcome": "OPEN",
  "outcome_date": null,
  "invalidation_fired": null,
  "themes": [
    "consumer-discretionary-rotation"
  ],
  "tags": [],
  "sources": [],
  "notes": [
    "CMG completed a 50-for-1 stock split in June 2024; all price levels here are post-split and are not comparable to pre-2024 quotes.",
    "The Q3 FY2026 date of ~2026-10-28 comes from third-party earnings calendars; the company had not issued a scheduling release as of 2026-08-23.",
    "Published targets span $36 (Guggenheim, Neutral) to $45 (Argus, BTIG) — dispersion, not consensus. Treat any single target as one desk's view.",
    "The jalapeño Salmonella outbreak also produced illness clusters at QDOBA; CDC/FDA trace it to one external supply chain, so it is not a Chipotle-only operating event.",
    "$1.7B of buyback authorization remained at 2026-06-30, making the issuer a recurring bid whose pace is only disclosed quarterly.",
    "CDC states the true case count is likely higher than reported and may extend beyond the 32 states with known illnesses."
  ],
  "body_markdown": "\n> **Refresh (2026-08-23):** the break condition published on 2026-08-15 — a weekly close below $32 — did not fire. The opposite happened. Between the 2026-08-14 close of $33.50 and the 2026-08-21 close of $36.90 the stock added 10.1%, reclaiming the $35 shelf that had failed the week before, while the federal case count in the same window went the other way: 345 cases across 27 states as of 2026-08-14, 431 across 32 states as of 2026-08-19. The leg being priced has changed from damage to repair.\n\n## CMG — Chipotle Mexican Grill, Inc.\n\n## Current Thesis\n\nThe narrative an investor would be buying is a supplier-caused brand shock that the market has begun to date rather than extrapolate. Two observables sit on top of each other. First, the CDC/FDA count expanded roughly 25% — 431 infections, 32 states, 57 hospitalizations, zero deaths as of 2026-08-19 — and the stock rose through it. Second, the CDC's own timeline puts illness onsets between 2026-06-19 and 2026-07-20, so the contaminated lot had cleared the system weeks before the story reached the tape on 2026-08-04. A rising case count on that page is an accounting of a closed exposure window, and the price action since 08-14 says the market has started reading it that way.\n\nWhat is still unmeasured is consumer behaviour after 2026-08-04. Q2 (2026-07-29) showed transactions +1.0% and average check +1.2%; no scheduled event tests whether that survived the headline period until the Q3 print, which third-party calendars place at ~2026-10-28 and which the company had not confirmed as of 2026-08-23. The 2026-08-21 close of $36.90 leaves the shares 15.4% under the 52-week high of $43.64, with RSI(14) at 47.8 — a reclaim without thrust.\n\n## Bull Case\n\n- **The case count and the price separated.** 345 cases / 27 states / 36 hospitalizations at 2026-08-14 versus 431 / 32 / 57 at 2026-08-19 (FDA statement, 2026-08-19), against a 2026-08-21 close of $36.90 versus $33.50 on 2026-08-14. Expansion of a backward-looking tally stopped moving the stock.\n- **The exposure window is closed and documented.** CDC lists illness onset dates from 2026-06-19 to 2026-07-20; Taylor Fresh Foods recalled jalapeño peppers on 2026-08-08; Chipotle and QDOBA removed the affected product, and CDC and FDA state there is no current ongoing risk from these establishments.\n- **The vector is a named third party.** Jalapeños from Sinaloa, Mexico distributed by Coast Citrus Distributors, with FDA downstream recalls across 26 states on 2026-08-10 and Taylor Farms recall coverage on 2026-08-11. QDOBA sits in the same case set, which cuts against a Chipotle-specific operating failure.\n- **The Q2 quarter itself raised guidance.** Revenue $3.348B, +9.3% YoY; comparable sales +2.2%; full-year comp guidance lifted to low-single-digit growth with 350–370 openings planned, ~80% with Chipotlanes (2026-07-29 release).\n- **The issuer is a disclosed marginal buyer.** $630.7M repurchased in Q2 at an average $32.55/share, $1.7B of authorization left at 2026-06-30, funded against $228.2M cash and $449.7M current investments.\n- **Unit expansion continued through the shock.** Press coverage dated 2026-08-17 reports the first Chipotle restaurant in Saudi Arabia opened that day. Digital was 38.3% of Q2 food and beverage revenue versus 35.5% a year earlier.\n\n## Bear Case\n\n- **Margin compression is already on the tape.** Restaurant-level operating margin 25.2% versus 27.4% (-220bp) and operating margin 15.7% versus 18.2% at Q2 2026-07-29, with diluted EPS flat at $0.32 on 9.3% revenue growth. That happened before any outbreak effect.\n- **The repair is five sessions old and fundamentally unconfirmed.** No company datapoint between 2026-08-23 and ~2026-10-28 measures post-08-04 traffic. Everything in between is health-agency updates, recall notices and lawsuit filings.\n- **The investigation has not closed.** No outbreak-over declaration as of 2026-08-19, and the CDC states the true number of sick people is likely higher and the outbreak may not be limited to states with known illnesses.\n- **Sell-side positioning is one-sided.** 24 Buy, 9 Hold and 0 Sell across 33 covering analysts (24/7 Wall St, 2026-08-11). Ratings can unwind through downgrades before they unwind through price.\n- **Published targets straddle the current quote.** Guggenheim held Neutral at $36 (2026-07-31) and Piper Sandler held Overweight at $39 (2026-07-30) against Argus $45 (2026-08-04) and BTIG $45 (2026-08-05). The low end of that dispersion sits under the 2026-08-21 close of $36.90.\n- **Remediation and litigation cost is unquantified.** Individual suits followed the August cluster; no reserve has been disclosed.\n\n## Setup & Price Structure\n\n- **Reference levels.** The 2026-08-21 close was $36.90, 15.4% below the 52-week high of $43.64, with a three-month price change of +12.2% and RSI(14) at 47.8.\n- **The structural change since 2026-08-15.** The $35 shelf broke on the 2026-08-14 close of $33.50 and was taken back on the 2026-08-21 close of $36.90. That reclaim, achieved against a rising federal case count, is the entire new information in the chart.\n- **$32.55 as a reference.** That is the average price the company itself paid in Q2. Price under it would put the issuer's own Q2 execution underwater and would mark a full round-trip of the recovery.\n- **The narrative is maturing.** The outbreak story is fully public and the flow is thinning — 12 of the 15 news items in the trailing 30 days cluster between 2026-08-04 and 2026-08-11, with a single follow-up on 2026-08-19. Attention peaked in the first week of August; the price leg is still working while the headline supply decays. It is not accelerating (no fresh attention driver, no new participant class) and not dead (the $35 structure was recovered).\n- **Crowding and positioning observables, stated as observables:** zero Sell ratings out of 33 as of 2026-08-11; no earnings date inside 30 days, so no imminent print compresses the window; $1.7B of buyback authorization outstanding with pace disclosed only once a quarter; RSI 47.8 is mid-range, so the recovery is not stretched; the recent-filings record for this period shows no Form 4 insider activity and no equity issuance.\n\n## Catalyst Calendar (next 30 days)\n\n- **No company-scheduled event falls between 2026-08-23 and 2026-09-22.** That absence is itself the setup: the information vacuum flagged on 2026-08-15 is still open and now runs about nine weeks.\n- **~2026-10-28 (est.) — Q3 FY2026 results.** Third-party earnings calendars (Nasdaq, TipRanks) carry 2026-10-28; the company had not issued a date advisory as of 2026-08-23. Chipotle's practice has been to publish a scheduling release roughly two to three weeks ahead, which would land in early-to-mid October.\n\n## Elapsed catalysts\n\n- **Unscheduled, rolling — CDC/FDA updates to the javiana-08-26 investigation.** Last update 2026-08-19 (431 cases, 32 states, 57 hospitalizations). *(passed 7d ago)*\n- **Unscheduled — further FDA recall action or a new state linkage.** Prior actions: downstream recalls across 26 states on 2026-08-10; Taylor Farms jalapeño recall reported 2026-08-11. *(passed 15d ago)*\n- **~September 2026 (est.) — third-party card-spend and foot-traffic trackers covering August.** These are not company data and are not uniformly published, but they are the only plausible outside read on post-2026-08-04 traffic before the Q3 print. *(passed 22d ago)*\n\n## What Would Change Our Mind\n\nThe repair leg stands on one structural fact: the $35 shelf that failed on the 2026-08-14 close of $33.50 was taken back by 2026-08-21. Giving that shelf back would say the market re-classified the outbreak from a headline event to a demand event without waiting for the numbers. The gradeable form of that is a weekly close below $34, which surrenders the entire post-08-14 recovery and returns price into the drawdown range.\n\nOn fundamentals, four things would flip the read independently of price: comparable-sales transactions printing negative YoY at the ~2026-10-28 Q3 report against +1.0% in Q2; restaurant-level operating margin below 25.2% for a second consecutive quarter; Q3 repurchases materially below the $630.7M spent in Q2 with the $1.7B authorization left largely idle; or the first published Sell rating, or a cluster of target cuts under the $36 Guggenheim level, breaking a 24-Buy/0-Sell distribution.\n\nOn the other side, an outbreak-over declaration from CDC with the count static near 431 would remove the open-ended headline stream ahead of the print. If ~2026-10-28 comes and goes with comps still positive and margin stabilised, the frame moves from repair back to the ordinary unit-growth and margin argument that governed this name before 2026-08-04.\n\n## Correlation Notes\n\n- **The co-implicated brand offers no listed read-through.** QDOBA is privately held, as are Taylor Farms and Coast Citrus Distributors, so the outbreak's supply chain has no traded proxy. Anyone sizing the event from equity prices is looking at one instrument.\n- **The move has been idiosyncratic, not sector beta.** The 2026-08-04 drop of roughly 9.7% and the 08-14-to-08-21 recovery both track health-agency dates rather than the consumer-discretionary tape; CMG is an S&P 500 constituent and the index did not trace those swings.\n- **Fast-casual comparables (CAVA, WING, SG) share the traffic cycle but not the food-safety event.** If Q3 comps at those names show industry-wide transaction softness, the ~2026-10-28 print becomes harder to attribute cleanly to the outbreak, which cuts both ways for the recovery frame.\n- **Input-cost exposure runs through Mexico.** Jalapeños in this instance came from Sinaloa; avocado sourcing is concentrated in Mexico as well, so tariff and cross-border trade headlines are a separate, recurring channel into the margin line that is already down 220bp YoY.\n- **The 50-for-1 split of June 2024 means every level here is post-split** and none of it is comparable to pre-2024 chart history or to older published targets.",
  "first_seen": "2026-04-26",
  "last_analyzed": "2026-08-24T06:11:51+00:00",
  "last_synthesized": "2026-08-23",
  "last_update_source": "theme_discovery",
  "license": "Content © FrontierPicks. Cite the canonical URL."
}